Press Releases

Oropharynxkarzinom: Frühdiagnostik durch HPV-E6

DocCheck News       4. Dezember 2017

Die steigende Zahl von Krebsfällen im Mundrachenraum gilt als Folge einer Infektion mit HPV. Krebsforscher entwickelten nun einen Bluttest auf bestimmte Antikörper. Mit diesem lassen sich gefährdete Personen mehr als zehn Jahre vor der möglichen Diagnose identifizieren. More ...

A biomarker for cancer of the oropharynx

DKFZ News       03. April 2017

A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of developing this type of cancer ten years or more before cancer diagnosis. More ...

Early HPV testing could detect sexually transmitted oral cancer

DKFZ News       18. June 2013

Antibodies to a high-risk type of human papillomavirus (HPV16) could help detect oropharyngeal(1) cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Oncology. More ...

to top